| Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma S Mithraprabhu, A Kalff, A Chow, T Khong, A Spencer Epigenetics 9 (11), 1511-1520, 2014 | 186 | 2014 |
| The t (4; 14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies A Kalff, A Spencer Blood cancer journal 2 (9), e89-e89, 2012 | 164 | 2012 |
| Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma S Mithraprabhu, T Khong, M Ramachandran, A Chow, D Klarica, L Mai, ... Leukemia 31 (8), 1695-1705, 2017 | 122 | 2017 |
| Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients S Mithraprabhu, R Morley, T Khong, A Kalff, K Bergin, J Hocking, ... Leukemia 33 (8), 2022-2033, 2019 | 61 | 2019 |
| The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults A Kalff, C Dowsing, A Grigg British journal of haematology 149 (5), 768-774, 2010 | 59 | 2010 |
| Phase 1, first-in-human study of MEDI2228, a BCMA-targeted ADC in patients with relapsed/refractory multiple myeloma SK Kumar, M Migkou, M Bhutani, A Spencer, S Ailawadhi, A Kalff, ... Blood 136, 26-27, 2020 | 54 | 2020 |
| Central nervous system multiple myeloma–potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains D Lee, A Kalff, M Low, S Gangatharan, P Ho, A Bajel, D Ritchie, A Grigg, ... British journal of haematology 162 (3), 371-375, 2013 | 50 | 2013 |
| Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies J Hocking, S Mithraprabhu, A Kalff, A Spencer Cancer biology & medicine 13 (2), 215, 2016 | 47 | 2016 |
| Lenalidomide in multiple myeloma: current status and future potential H Quach, A Kalff, A Spencer American journal of hematology 87 (12), 1089-1095, 2012 | 36 | 2012 |
| Bisphosphonate guidelines for treatment and prevention of myeloma bone disease OL Lee, N Horvath, C Lee, D Joshua, J Ho, J Szer, H Quach, A Spencer, ... Internal medicine journal 47 (8), 938-951, 2017 | 30 | 2017 |
| Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study) A Kalff, T Khong, S Mithraprabhu, K Bergin, J Reynolds, KM Bowen, ... Leukemia & lymphoma, 2019 | 17 | 2019 |
| Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group D Talaulikar, CS Tam, D Joshua, JP Ho, J Szer, H Quach, A Spencer, ... Internal medicine journal 47 (1), 35-49, 2017 | 17 | 2017 |
| Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients A Bryant, I Nivison-Smith, ES Pillai, G Kennedy, A Kalff, D Ritchie, ... Bone marrow transplantation 49 (1), 17-23, 2014 | 17 | 2014 |
| DCEP as a bridge to ongoing therapies for advanced relapsed and/or refractory multiple myeloma HLA Yuen, MSY Low, P Fedele, A Kalff, P Walker, K Bergin, ... Leukemia & Lymphoma 59 (12), 2842-2846, 2018 | 16 | 2018 |
| Phase 3 study of subcutaneous bortezomib, thalidomide, and prednisolone consolidation after subcutaneous bortezomib-based induction and autologous stem cell transplantation in … N Horvath, A Spencer, M Kenealy, D Joshua, PJ Campbell, JJ Lee, J Hou, ... Leukemia & lymphoma, 2019 | 14 | 2019 |
| Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma P Campbell, P Walker, S Avery, S Patil, D Curtis, A Schwarer, A Wei, ... Blood cancer journal 4 (5), e213-e213, 2014 | 12 | 2014 |
| Thalidomide and prednisolone versus prednisolone alone as consolidation therapy after autologous stem-cell transplantation in patients with newly diagnosed multiple myeloma … A Kalff, N Kennedy, A Smiley, HM Prince, AW Roberts, K Bradstock, ... The Lancet Haematology 1 (3), e112-e119, 2014 | 10 | 2014 |
| Idiopathic systemic capillary leak syndrome presenting as septic shock: a case report EP Raith, JF Ihle, J Jamieson, A Kalff, J Bosco Heart & Lung 47 (4), 425-428, 2018 | 9 | 2018 |
| Laboratory tumor lysis syndrome complicating LBH589 therapy in a patient with acute myeloid leukaemia A Kalff, J Shortt, J Farr, R McLennan, A Lui, J Scott, A Spencer Haematologica 93 (1), e16-e17, 2008 | 9 | 2008 |
| The utility of EuroFlow MRD assessment in real-world multiple myeloma practice R Turner, A Kalff, K Bergin, M Gorniak, S Fleming, A Spencer Frontiers in Oncology 12, 820605, 2022 | 8 | 2022 |
